About us
Keena Consulting was born in 2021, the result of more than ten years of expertise in clinical development across various therapeutic areas: cancerology, neurology, nephrology, cardiology, ophthalmology, rare diseases, medical devices, etc.
Founded after careful consideration, the company emerged from the conviction that it was essential to mobilize proven experts to support pharmaceutical laboratories, biotechnology companies, CROs and medical device manufacturers, in response to specific needs, whether one-off or long-term, to effectively manage their clinical trials.
Keena Consulting supports its clients in all critical stages of their studies: from start-up activities (selection of investigation centers, regulatory submissions, negotiation of contracts with institutions) to international project management, including the opening of centers, monitoring of clinical trials and site closure.
Keena Consulting distinguishes itself through a tailor-made approach, enabling its partners to navigate the challenges of clinical development with expertise, flexibility and rigor.
Our Mission
Keena Consulting is a company specializing in consulting for pharmaceutical laboratories and medical device companies.
We offer a set of key services to support our clients in the management of their clinical studies and regulatory procedures.
Our Vision
-
Expansion of the Customer Base: Diversify the customer portfolio by attracting 5 new major customers (CROs, biotechnology companies and medical device manufacturers) in the next three years, particularly in Europe and the United States.
-
Strengthening Complete CRO Services: Develop and structure a complete range of CRO services by 2025, including data management, medical review and pharmacovigilance, thus enabling comprehensive support for clinical trials.
-
Development of Strategic Partnerships: Establish partnerships with key service providers (analysis laboratories, core labs, specialized consultants) to optimize the efficiency and quality of clinical trials, and maximize the capacity to intervene on major international projects.
-
Positioning as a Leader in the Rare Diseases and Medical Devices Sector: By 2026, become a benchmark player for the management of clinical trials in rare diseases and medical devices, thanks to technical expertise and increased capacity in project management specific to these areas.
-
Certification and Compliance: Obtain and maintain the necessary ISO and GCP certifications to demonstrate the quality and compliance of Keena Consulting's processes, particularly as part of the expansion of its full CRO business.
Our Values
-
Excellence and Expertise: Ensure high quality standards in all missions to guarantee the success of client projects.
-
Integrity and Transparency: Act ethically and transparently in all interactions, whether with customers, partners or teams.
-
Innovation and Agility: Encourage innovation to anticipate customer needs and quickly adapt to changes in the healthcare sector. Agility allows Keena Consulting to offer tailor-made solutions, taking into account new regulatory requirements, technological advances and the needs of each project.
-
Customer Engagement: Putting the customer at the center of priorities and tailoring services to meet their specific expectations. This includes proactive communication and continuous availability, to ensure that projects progress smoothly and efficiently.
-
Responsibility and Compliance: Committed to meeting international regulatory requirements and good clinical practices, ensuring solutions that are both safe and compliant.
-
Collaboration and Team: Foster collaboration and knowledge sharing within the team and with partners to create a stimulating and productive work environment.
Our Success Stories
Keena Consulting has achieved several notable successes through its collaborations with IQVIA, ICON and Occlutech.
With IQVIA, she led trials in the areas of nephrology and oncology, ensuring rigorous site monitoring and full compliance with international standards.
With ICON, she oversaw oncology studies, optimizing monitoring processes and strengthening data quality.
At Occlutech, Keena Consulting has played a critical role in the initiation and management of several clinical trials. One of these trials, recently initiated, saw the selection of all critical vendors, including CROs and Corelab, country and site selection, staff recruitment, and establishment of key committees (Patient Eligibility Committee, DSMB, Adverse Event Review Board, etc.).
The team also drafted and validated all study documents and managed regulatory submissions in each participating country. Another trial, successfully completed, was conducted through to data cleaning, investigational center closure, and clinical study report (CSR) validation.
These projects mark crucial milestones in Keena Consulting's journey and reflect its ability to conduct end-to-end clinical trials, ensuring the necessary rigor and compliance at every stage.
.png)
.png)
